Ensysce Biosciences (ENSCW) Equity Average (2020 - 2025)
Historic Equity Average for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $2.3 million.
- Ensysce Biosciences' Equity Average fell 4731.09% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 4731.09%. This contributed to the annual value of $1.5 million for FY2024, which is 16531.1% up from last year.
- According to the latest figures from Q3 2025, Ensysce Biosciences' Equity Average is $2.3 million, which was down 4731.09% from $3.2 million recorded in Q2 2025.
- Over the past 5 years, Ensysce Biosciences' Equity Average peaked at $5.3 million during Q4 2024, and registered a low of -$5.2 million during Q4 2022.
- For the 5-year period, Ensysce Biosciences' Equity Average averaged around $258805.3, with its median value being $416926.0 (2023).
- Per our database at Business Quant, Ensysce Biosciences' Equity Average tumbled by 41514.93% in 2021 and then surged by 117320.34% in 2024.
- Ensysce Biosciences' Equity Average (Quarter) stood at -$4.3 million in 2021, then dropped by 22.34% to -$5.2 million in 2022, then soared by 107.98% to $416926.0 in 2023, then skyrocketed by 1173.2% to $5.3 million in 2024, then crashed by 56.74% to $2.3 million in 2025.
- Its Equity Average stands at $2.3 million for Q3 2025, versus $3.2 million for Q2 2025 and $3.4 million for Q1 2025.